| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |